Article

Osteomyelitis in the head and neck.

Department of Otolaryngology - Head & Neck Surgery, Kasturba Medical College, Mangalore, India.
Acta Oto-Laryngologica (Impact Factor: 1.11). 03/2007; 127(2):194-205. DOI: 10.1080/00016480600818054
Source: PubMed

ABSTRACT All bones of the facial skeleton and spine are susceptible to osteomyelitis due to various predisposing conditions. Current radiological tools are sufficient to provide adequate diagnosis. Treatment can be conservative resection of the diseased bone with adequate clearance in all cases except in cases of osteomyelitis due to osteoradionecrosis (ORN) where resection has to be more radical.
In today's antibiotic era, osteomyelitis in the head and neck is a rare occurrence. Dealing with osteomyelitis in head and neck bones is not the same as in other bones of the body due to the nature of the bones, complex anatomy of the region, and esthetics. Our purpose was to analyze the behavior of osteomyelitis in the head and neck bones and its management.
A total of 84 cases of osteomyelitis in head and neck were reviewed in a 10-year period. Pus for culture, antibiotic sensitivity, and radiology were the main investigations. A medical line of treatment was effective in acute cases. Surgery was opted for in chronic cases.
Mandible, frontal bone, cervical spine, maxilla, temporal bones, and nasal bones were involved, in descending order of frequency, i.e. the mandible was the most common bone affected. Nine patients were diagnosed as having acute osteomyelitis (11%); 75 were diagnosed as having chronic osteomyelitis (89%). Radiation-induced ORN leading to osteomyelitis was the most common cause of osteomyelitis of the mandible (13 of the 32 cases; 41%). Odontogenic infections and chronic sinusitis each gave rise to osteomyelitis in 3 of 10 cases (30%) of the patients with osteomyelitis of the maxilla. Chronic sinusitis was the main cause of frontal bone osteomyelitis in all 20 cases (100%). Tuberculosis (10 of 15 cases; 67%) and malignancy (5 of 15 cases; 33%) were the main predisposing factors in cervical spine osteomyelitis. Malignant external otitis (MEO) with diabetes mellitus was an underlying factor in all four cases of osteomyelitis of the temporal bone. Of the 18 patients with a diagnosis of ORN, the mandible was found to be the most susceptible bone (13 cases; 72%), followed by the maxilla (four cases; 22%) and cervical spine (1 case). Acute osteomyelitis responded to antibiotics. Sequestrectomy was carried out in all chronic cases but in cases of ORN more radical surgery was performed.

0 Bookmarks
 · 
192 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: A reliable imaging technique is needed for follow-up of patients with temporal and facial osteomyelitis. Clinical outcome in 20 patients with suspected osteomyelitis of the temporal/mastoid, calvarium, and mandible facial bones was evaluated with 30 combined In-WBC/Tc-99m MDP bone single photon emission computed tomographic (SPECT) scans and 27 computed tomographic scans. Simultaneous dual-tracer 25-minute SPECT scans were acquired 18 to 20 hours after radiotracer injection by use of a three-detector system. Diagnosis of the 20 patients (age range, 3 to 74 years) included 8 with facial osteomyelitis, 6 with malignant otitis externa, 3 with mandibular osteomyelitis, and 3 with calvarial osteomyelitis. Diagnosis was confirmed by biopsy/culture results in 18 patients and by endoscopic and clinical evaluation in 2 patients with initial negative scans. Of the 30 In-WBC/MDP scans, 15 were true-positive, 13 true-negative, 1 false-negative, and 1 equivocal. Of a total of 27 CT scans, 9 were true-positive, 5 false-negative, and 1 equivocal in patients with biopsy-proven osteomyelitis. Three computed tomographic scans were false-positive and 1 was equivocal in patients without osteomyelitis, because of concurrent postoperative bone abnormalities. Additionally, 8 computed tomographic scans were true-negative. These results suggest that dual In-WBC/Tc-99m MDP bone SPECT scintigraphy provides an accurate imaging modality for diagnosis and follow-up of temporal and facial osteomyelitis when existing clinical or postoperative bone changes make it difficult to detect active osteomyelitis by computed tomographic scan.
    Otolaryngology Head and Neck Surgery 08/1995; 113(1):36-41. · 1.73 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: HintergrundRezidivierende Exazerbationen bei chronischer Otitis externa stellen für den Behandler eine besondere Herausforderung dar. Untersucht werden sollte die therapeutische Wirksamkeit einer neuen Klasse von lokal applizierbaren Immunmodulatoren mit antiinflammatorischem, nichtsteroidalem Wirkmechanismus. Patienten und MethodenIn einer prospektiven Studie an 33 Patienten erfolgte alle 2 (–3) Tage eine Streifeneinlage mit Tacrolimus-Salbe (Protopic® 0,1%), insgesamt 3-mal ein Streifenwechsel. Der Behandlungserfolg wurde durch Nachuntersuchungen, anhand einer Videodokumentation und eines standardisierten Befundbogens beurteilt. Ergebnisse28 Patienten zeigten eine signifikante Verbesserung der klinischen Symptomatik, 13 von ihnen eine komplette Heilung (Follow-up: 10–22 Monate). Bei Rezidiven (15 Fälle) waren die symptomfreien Intervalle signifikant verlängert und die Anzahl weiterer Episoden verringert. SchlussfolgerungDank ihrer sicheren und erfolgreichen antientzündlichen Wirkung stellen topische Immunmodulatoren eine neue Alternative bei chronisch therapieresistenter Otitis externa dar. BackgroundRecurrent exacerbation of chronic external otitis represents a special challenge for the attending physician. The goal of our study was to evaluate the effectiveness of novel topical immunomodulators acting through an anti-inflammatory, nonsteroidal mechanism. Patients and MethodsIn a prospective study, in 33 patients an ear wick containing tacrolimus ointment (Protopic 0.1%) was inserted every 2–3 days. Altogether, the wick was changed three times. Therapeutic outcomes were assessed by reexaminations, video-otoscopy, and a standardized findings sheet. ResultsTwenty-eight patients showed significant improvement of clinical symptoms, with 13 of them showing complete healing (follow-up 10–22 months). Relapses (15 cases) were associated with significantly extended symptom-free intervals and reduced numbers of further recurrent episodes. ConclusionsBecause of the safe and successful anti-inflammatory effects, topical immunomodulators represent a new alternative in chronic inflammatory stages of otherwise therapy-resistant external otitis.
    HNO 01/2008; 56(5):530-537. · 0.42 Impact Factor
  • Source
    International journal of odontostomatology. 09/2010; 4(2):197-202.

Full-text

View
57 Downloads
Available from
May 22, 2014